← Back to patent-cliff list
CAS 180340-05-0
4-([1,1'-biphenyl]-2-carboxamido)benzoyl chloride
Codes: CONI-019
Application context (from source-drug indications)
HyponatraemiaConivaptan HydrochlorideAcute decompensated heart failureConivaptan HydrochlorideHeart failureConivaptan HydrochlorideLiver diseaseConivaptan HydrochlorideTraumatic brain injuryConivaptan HydrochlorideKidney diseaseConivaptan Hydrochloride
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Conivaptan Hydrochloride | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
[1,1'-biphenyl]-2-carboxylic acid→2-methyl-1,4,5,6-tetrahydrobenzo[b]imidazo[4,5-d]azepine→[1,1'-biphenyl]-2-carbonyl chloride→4-aminobenzoic acid→4-([1,1'-biphenyl]-2-carboxamido)benzoic acid→4-([1,1'-biphenyl]-2-carboxamido)benzoyl chloride
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.